Bexagliflozin

Overview

Bexagliflozin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1808388).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Bexagliflozin expires 4 Oct 2041 and exclusivity 20 Jan 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

Canonical SMILES

C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl

InChIKey

BTCRKOKVYTVOLU-SJSRKZJXSA-N